Ashfield Commercial & Medical Services, part of UDG Healthcare plc, has announced that Julia Kelly has joined the company as Vice President of Business Development for Ashfield’s U.S. operations, effective August 8th.
She will be located at the company’s U.S. headquarters in Ivyland, PA, with responsibility for expanding the clinical and commercial portfolio of services and leveraging her extensive experience in the life sciences industry.
Julia comes to Ashfield from C3i Healthcare Solutions, a division of Telerx, where she was a Vice President of Account Management, responsible for the growth and management of multi-channel solutions for global healthcare clients.
Prior to C3i, Julia held various executive sales, marketing, and business development roles with Puracap Pharmaceutical, inVentiv Health, and the Mead Johnson Nutrition, a former Division of Bristol-Myers Squibb.
About her appointment, Julia said, “With the significant support of its global infrastructure, Ashfield is well poised for significant growth in the U.S. market place. I look forward to contributing to our success and that of our clients, through the delivery of our best-in-class Commercial and Clinical services.”
Mike Stout, CEO of Ashfield Commercial & Clinical said, “Julia is a dynamic leader whose expertise and experience will be critical to our growth. We are excited to have her on our team to help us expand the Ashfield footprint through expansion of our client service portfolio.”
A graduate and alumni association member of Pennsylvania State University, Julia is an active member of numerous professional and community associations, the Women’s Business Leaders of America, the American Dietetic Association, the Project Athena Foundation, and the Healthcare Business Women’s Association, where she has was recently a director at large.